1 active not recruiting, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Unknown 1 |
Follow NIDDM: new trials by email Literature Review of NIDDM trials Research Report on NIDDM
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo Metformin Extended Release (ER) Oral Tablet, Placebo - NIDDM, Obesity | Phase 4 | Active not recruiting | University of California, Los Angeles | 150 | 2023-11-22 | 2026-06-08 |
| Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs candesartan - NIDDM | Phase 4 | Unknown | Rambam Health Care Campus | 20 | 2006-02-23 |
Diabetes Mellitus, Type 2 (2) · Obesity (1)
Diabetes Mellitus (2) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Body Weight (1) · Nutrition Disorders (1) · Overnutrition (1) · Overweight (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Tablets (1) · candesartan (1)
Rambam Health Care Campus (1) · University of California, Los Angeles (1)
Israel (1) · United States (1)
Shlomo Keidar, MD (1) · Vijiya Surampudi, MD (1)